April 12, 2018 – Executive search firm Coulter Partners has placed Phil Offer as the new CEO of George Health Technologies. Based in Sydney, Australia, his primary focus will be to develop the company’s business growth strategy and commercial opportunities.
“This was a truly global search for a truly global role and we developed multiple candidate relationships, in multiple time zones,” said Geoff Dobson, director at Coulter Partners. “It took us from Europe to North America, to the Far East, including Singapore, Hong Kong and China, and to Australia. Two distinct candidate pools evolved: individuals from a software background that had moved into the healthcare sector, and senior individuals in the life sciences sector that had latterly moved into digital health.”
The George Institute’s huge reputation, in Australia and beyond, he said, and an exceptional global team that is making a real difference to global health, drew strong lead candidates, Mr. Dobson said.
Mr. Offer has extensive leadership experience across multiple sectors that include digital health technology, telco, data analytics and consulting. He is a senior executive with a track record of accelerating growth through the smart adoption of new technology. Mr. Offer has been a proven CEO within digital health since 2013, first with MedicalDirector, Primary Healthcare Ltd. and then with management consultancy Cimbio Group in Australia. Prior to 2013, he spent 16 years in senior management roles in the telecoms industry and was vice president, mobility and convergence, for Singtel Optus.
|Check out our latest upload from Coulter Partners|
Mr. Offer also brings a strong track record of launching new products and services both in the digital health arena and within the mobile telecoms business. He started his career as a chartered accountant with Price Waterhouse before moving into consumer marketing and general management roles, in large to mid-sized companies.
George Health Technologies, a division of George Institute for Global Health, has developed a unique digital clinical “intelligent” disease management system for the simultaneous management of multiple noncommunicable diseases. It offers integrated applications for healthcare providers and patients, as well as the knowhow to modify and integrate these algorithms into customer clinical service delivery systems on a digital platform.
“I look forward to contributing to the George Health’s unique mission to reduce the social and financial burden of non-communicable diseases whilst delivering a competitive financial return for shareholders,” Mr. Offer said.
Life Sciences Specialists
Headquartered in London, Coulter Partners is a senior-level executive search boutique focused exclusively on identifying global life sciences leaders and board directors. The firm serves clients in the pharmaceuticals, biotechnology, medical devices, diagnostics, CRO and services sectors. Coulter currently operates overseas offices in the U.K., Germany, Switzerland and Denmark. In the U.S., the firm has offices in Cambridge, MA; Princeton, NJ; Pittsburgh; Los Angeles; and Short Hills, NJ.
Tapping Outside Talent for Life Science and Healthcare
For these top 50 executive recruiters working in the life science and healthcare sectors, the last decade has been one of transformation. Pressure on pricing, regulatory changes, emerging innovations, growth, and an uncertain political environment have all helped shape a new field of play.
|Top 50 Ranking|
According to Deloitte’s global sector outlook report on life sciences, persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies as they try to navigate a new world of work. This will require a dramatic change in strategies for leadership, talent and human resources.
“Our sector has changed beyond anyone’s expectations over the last two decades,” said CEO Bianca Coulter. “We need to understand the appetites and needs of the major multinationals. This requires reach into all corners of the market. While our office network is growing, the key has been to have multilingual, multi-market experienced and connected researchers and consultants. Our team speaks many languages and has worked in all major bio-pharma markets and is organized as one P&L, to ensure collaborative information and experience sharing.”
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Will Schatz, Managing Editor – Hunt Scanlon Media